Origin Two 3D printer with Origin Cure
The Origin Two DLP printer in tandem with its own post-processing system, the Origin Cure, addresses the growing demand among manufacturers for injection-molding quality for short production runs. Additive manufacturing with the new Origin Two is designed to eliminate the high setup and tooling costs typical for low to medium volume production, while meeting customers’ most stringent precision requirements.
The Origin Two, with Origin Cure, enables manufacturers to:
- Ensure end parts meet required properties
- Bring production in-house
- Improve inventory management, lower warehousing costs with on-demand delivery of spare parts
- Consolidate part manufacturing into a single process with better consistency
It achieves repeatability of more than 93% within ±50µm across Origin Two printers, and surface finish smoothness up to RA 3µm, while maintaining high print speeds up to 20mm/hour.
https://www.stratasys.comExplore the October 2024 Issue
Check out more from this issue and find your next story to read.
Latest from Today's Medical Developments
- Best of 2024: #10 Article – Designing medical devices for every user
- Best of 2024: #10 News – 4 predictions for 2024: AI set to supercharge robotic automation
- Children’s National, FDA collaborate to advance pediatric device regulatory tools
- LK Metrology’s eco-friendliness CMMs
- Two patents for microfluidic valves
- AMADA WELD TECH’s blue diode laser technology
- Post-IMTS decline in manufacturing technology orders blunted
- ARS Automation’s FlexiBowl 200